NAMI Pharma Marketing Blog Grassley
View PDF of blog article here
Similar Posts
ACRE–A High Powered Harvard Stealth Pharma Front Group
ACRE’s mission is to persuade physicians that MORE rather than less industry involvement in Continuing Medical Education programs is good for patients–much as industry’s "Harry and Louise" ads were aimed at convincing the public that universal healthcare was BAD for them.
FDA Failed to Disclose Suicide Risk to Advisory Committee
The BMJ news report (below) is included in the Congressional Record transcript of the Congressional hearing at which FDA officials were grilled about why they prevented Dr. Andrew Mosholder from delivering his analysis report of the pediatric antidepressant clinical trials. http://a257.g.akamaitech.net/7/257/2422/12jan20051100/www.access.gpo.gov/congress/house/pdf/108hrg/96099.pdf
Debate Over Antidepressants: FDA role in suppressing damaging data – WSJ
WSJ: Debate Over Antidepressants: FDA role in suppressing damaging data Tue, 25 May 2004 How were drug manufacturers able to conceal vital evidence of harmful antidepressant drug effects? The answer is becoming clearer by the day: federal regulators and the psychiatrists who tested these drugs in clinical trials are invested…
Despite Undisclosed Deaths, 10 Heart Attacks FDA Allows Blood Substitute Experiment With No Conset
The Wall Street Journal reports: “The FDA is allowing Northfield [Laboratories, Inc] to test its blood substitute without the consent of the trauma patients, who often are unconscious.”
Infomail Archive 2004
Infomail 2004 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Dec 31: FDA to review “missing” drug company documents Dec 30: Family of Woman Killed by AIDS Drug Test Sues Doctors, Manufacturer Dec 30: Doctors, Too, Ask: Is This Drug Right? Dec 29: Bill would shield…
GAO Report Gives FDA Flunking Grade in Detecting Drug Dangers
“More than a year after the Food and Drug Administration announced it had strengthened its drug safety system, the agency still lacks a reliable system for keeping track of emerging problems, congressional investigators concluded in a report to be released today.” [Los Angeles Times, below]